HOME - The Journal of Precision Medicine

LATEST NEWS

Agilent Announces New SureSelect Human All Exon V8

adminpmls20162021-06-04T13:53:57-05:00June 4th, 2021|

New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma

adminpmls20162021-06-04T13:36:10-05:00June 4th, 2021|

Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting

adminpmls20162021-06-04T13:31:37-05:00June 4th, 2021|

Novartis announces Tabrecta® first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC

adminpmls20162021-06-04T13:27:57-05:00June 4th, 2021|

Bristol Myers Squibb Presents Data from CheckMate -648

adminpmls20162021-06-04T13:24:13-05:00June 4th, 2021|

PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discovery

adminpmls20162021-05-17T08:51:06-05:00May 17th, 2021|

Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.

adminpmls20162021-04-29T12:29:27-05:00April 29th, 2021|

Geisinger awarded $3.6 million to study genetics of cancer

adminpmls20162021-04-29T12:07:14-05:00April 29th, 2021|

Thermo Fisher Scientific Reports First Quarter 2021 Results

adminpmls20162021-04-29T12:05:32-05:00April 29th, 2021|

Agilent Announces New SureSelect Human All Exon V8 - thejournalofprecisionmedicine.com/agilent-announ…
1 week ago
New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma - thejournalofprecisionmedicine.com/new-research-f…
1 week ago
Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting - thejournalofprecisionmedicine.com/labcorp-to-int…
1 week ago

LATEST ISSUE

The Journal of Precision Medicine - March

Transitioning from Emerging to Established Companies and Technologies

Integrating biomarker and translational research in a drug development pipeline

New Disruptive Business Model: The Convergence of Precision Science, Precision Medicine, Precision Product Development, and Precision Commercialization

Industry challenges & opportunities for the integration of precision medicine tools at the point of care

Building Back Better: Leveraging Value-Based Payment to Build a More Resilient Health Care System

Questions on an agnostic AI system: A case study for an aortic aneurysm detection and other applications

Implementing the ACMG Guidelines for CNV in a Commercial Software Solution

Revitalizing pharma’s drug discovery pipelines

The Parallel Diagnostic Odysseys of Alzheimer’s Disease and NASH

Multidimensional Predictive Diagnostics: The GPS of Clinical Practice

The Human Touch: Improving In Vivo Evaluation of Biologics with Human-ized Immune System Models

From Cerebral Cavernous Malformation to cancer research: a one-size-fits-all path to precision medicines

Letter to the Journal: The COVID-19 innovation race, a case study

Personalized Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

ARCHIVE ISSUES

The Journal of Precision Medicine - December

December 2020

Articles include:
Letter to the Journal: The COVID-19 innovation race, a case study
Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

Read More

The Journal of Precision Medicine - September

September 2020

Articles include:
Cell and gene therapy: OVERVIEW, CURRENT LANDSCAPE AND FUTURE TRENDS
Pioneering precision medicine in rheumatoid arthritis

Read More

The Journal of Precision Medicine - June

June 2020

Articles include:
Using tears for precision diagnostics and the development of a potential new therapy for age- related macular degeneration
The dal-GenE trial: A case study of precision medicine in the cardiovascular setting

Read More

March 2020

Articles include:
Personalized Medicine in the Aftermath of COVID-19
Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease

Read More

LATEST NEWS

Agilent Announces New SureSelect Human All Exon V8

New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma

Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting

Novartis announces Tabrecta® first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC

Bristol Myers Squibb Presents Data from CheckMate -648

PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discovery

Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.

Geisinger awarded $3.6 million to study genetics of cancer

Thermo Fisher Scientific Reports First Quarter 2021 Results

Recent Tweets

LATEST ISSUE

ARCHIVE ISSUES

December 2020

September 2020

June 2020

March 2020

SUBSCRIBE